Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park
publication date: Jan 4, 2021
Shanghai Pharmaceuticals broke ground on a $1.8 billion, 3.2 million-square-foot industrial park that will add an increased focus on its novel drug development efforts. The company said the new site would develop cell and gene therapies and manufacture therapeutic antibodies. When completely built out, the facility will include 538,000 square feet for an incubation platform and another 861,000 square feet for antibody manufacturing. It will eventually house 120,000 liters of antibody reactors. More details....
Stock Symbols: (SHA: 601607; HK: 2607)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.